Execs On The Move: New Leaders for Vyaire, Nevro, And More In May 2023
An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.
You may also be interested in...
The Paris-based start-up has picked up a CE mark for the latest generation of its Maestro system, a tool designed to make laparoscopic surgery easier and safer.
The UK-based company has just raised $165m support the ongoing commercialization of the Versius robotic platform.
In Vivo's deal-making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – acquisition, alliance, or financing. This month’s column covers deals announced in August 2023. Data provided by Biomedtracker.